 |
Levoleucovorin |
|---|---|
| Trade Name | Fusilev |
| Orphan Indication | For use in conjunction with high-dose methotrexate in the treatment of osteosarcoma |
| USA Market Approval | USA |
| USA Designation Date | 1991-08-01 00:00:00 |
| Sponsor | Spectrum Pharmaceuticals, Inc.;157 Technology Drive;Irvine, California, 92618 |
